American Marconi Wireless News

NYSE - LSE

NGG	0.57%	75.19	$
SCS	2.3%	16.12	$
CMSD	0.34%	23.58	$
GSK	2.29%	47.19	$
RYCEF	-2.21%	13.58	$
BTI	0.9%	55.25	$
RBGPF	0%	79.04	$
BP	0.72%	35.98	$
CMSC	-0.3%	23.37	$
RIO	1.73%	69.99	$
BCE	0.78%	23.13	$
JRI	0.83%	13.27	$
VOD	2.15%	12.11	$
RELX	2.49%	40.6	$
BCC	4.2%	71.88	$
AZN	2.55%	91	$

Featured

Bolsonaro says ankle monitor tampering driven by 'paranoia'

Brazil's former president Jair Bolsonaro, detained after allegedly using a soldering iron on his court-ordered ankle monitor, argued Sunday that a state of "paranoia" had led him to tamper with the device.

What does US 'terrorist' designation for Venezuela mean?

Washington's designation of an alleged Venezuelan cartel as a foreign terrorist organization (FTO) takes effect on Monday, opening the door to new forms of US pressure on President Nicolas Maduro.

Last news

Mosaic Announces Third Quarter 2025 Results

TAMPA, FL / ACCESS Newswire / November 4, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for the third quarter of 2025. The company's earnings release and supplemental materials are available at https://investors.mosaicco.com/financials/quarterly-results.

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth

Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter!

Newsmax to Attend the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference

BOCA RATON, FL / ACCESS Newswire / November 4, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that management, including CEO Christopher Ruddy, will attend the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference being held in New York City from November 18-19, 2025.

Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation

With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a national leader in pharmaceutical compounding while pursuing its mission to elevate patient care through innovation, scale, and quality.

Exousia Pro Announces Breakthrough In Exosome-Based Delivery

Successful loading of CBD material accelerates the path to revenue.

FLEX(C) Launches TRACK-LOCK(TM) Wall-Mount Storage System At The 2025 SEMA Show

LAS VEGAS, NV / ACCESS Newswire / November 4, 2025 / During the 2025 SEMA Show, FLEX© is transforming the detailing workspace with the launch of its TRACK-LOCK™ wall-mount storage system.

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will be integral for continuing UTMD's future excellent performance.

SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development

CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to acknowledge recent FDA commentary and industry analyses signaling continued evolution of regulatory pathways for genome-editing technologies. These developments highlight increasing regulatory focus on precision-engineered genetic tools, non-viral delivery approaches, and scalable manufacturing frameworks.

CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 4, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that the CASI management team will participate at the Guggenheim Healthcare Innovation Conference 2025 in a fireside chat at 9:30 AM ET on November 12 in Boston, MA. CASI will also host one-on-one meetings with investors at the conference.

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last yearU.S. revenue increased 115% for the quarter and 86% for the six months ended September 30, 2025 compared to same periods last yearNet loss per share decreased 46% for the quarter and 42% for the six months ended September 30, 2025 compared to same periods last year

VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System

Volume-based contract with no revenue ceiling covers virtual urgent care and behavioral health across more than 100 facilities; services commence January 1, 2026.

Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder

Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder.

Jerash Holdings to Report Financial Results for Fiscal 2026 Second Quarter on Wednesday, November 12, 2025

FAIRFIELD, NJ / ACCESS Newswire / November 4, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made sportswear and outerwear for leading global brands, today announced it will release its financial results for its fiscal 2026 second quarter ended September 30, 2025, before the market opens on Wednesday, November 12, 2025. The Company will host an investor conference call the same day.

Reservoir Media Announces Second Quarter Fiscal 2026 Results

Double-Digit Growth in Recorded Music Driven by Digital and Synch DemandOutlook for Revenue and Adj. EBITDA Raised for Fiscal 2026

Specificity Readies for Next Phase of Growth with Effective S-1 Registration Statement Enabling Access to Expansion Capital

Successfully Completes the Company's Process of Regaining Full SEC Compliance

Mosaic Announces Completion of Sale of Potash Mining Operations in Brazil to VL Mineracao

TAMPA, FL / ACCESS Newswire / November 4, 2025 / The Mosaic Company (NYSE:MOS) announced today the completion of the previously announced transaction with VL Mineração Ltda. ("VL Mineração") for the sale of Mosaic Potássio Mineração Ltda., the entity that operates the Taquari-Vassouras potash mine located in Rosário do Catete, Sergipe, Brazil. VL Mineração will take over the mining and processing of potash, as well as maintenance and other obligations. In exchange, Mosaic will receive $27 million (USD) in cash, with $12 million paid at closing, $10 million one year after closing, and up to $5 million over six years as contingent payments. VL Mineração will assume responsibility for approximately $22 million in asset retirement obligations (ARO).

Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5

Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made affordable and accessible by the Compassion Center; Sponsors urged to confirm placements as inventory nears capacity

BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH, has received an "Intention to Grant" notification from the European Patent Office (EPO) for European patent application no. 23 729 446.7, covering a sublingual, orally dispersible thin-film formulation of cladribine for the treatment of multiple sclerosis (MS) and related neurodegenerative diseases.

Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding

Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation TechnologyExpert consensus predicts integration of CTC testing into routine clinical practice within 5 yearsCTCs provide distinct and impactful information that is not captured by circulating tumour DNA (ctDNA)40% of the expert panel identified the Parsortix® platform as the most promising next generation technology for clinical applications

Starbucks cedes China control to Boyu Capital

Starbucks announced Monday it will sell a controlling stake in its Chinese retail operations to investment firm Boyu Capital in a deal valuing the business at around $4 billion.

Worker rescued after medieval tower partly collapses in Rome

Rescuers on Monday saved a worker who became trapped when the medieval tower he was helping renovate in Rome partly collapsed, city authorities said.

Trial opens in 1st US civil case on 2019 Boeing MAX crash

Relatives of victims in the fatal crash of a Boeing 737 MAX plane operated by Ethiopian Airlines headed to court Monday for the first civil trial relating to the 2019 calamity.

Medieval tower partially collapses in Rome, trapping worker

A medieval tower in central Rome that was under renovation partially collapsed on Monday, with one worker trapped alive under rubble, authorities said.

Shein bans sex dolls after France outrage over 'childlike' ones

Asian e-commerce giant Shein said Monday it was banning all sex dolls from sale on its sites after French authorities condemned it for featuring ones resembling children.

Ex-France international Ben Yedder to stand trial on rape charges

Former French international Wissam Ben Yedder will stand trial for alleged rape, attempted rape, and sexual assault, the prosecutor's office in Nice told AFP on Monday.

Christian, Muslim Nigerians push back on threatened US strikes

Nigerians across the religious spectrum pushed back Monday on US President Donald Trump's threats of military intervention over the killing of Christians in the country.

'Heroic' worker praised as man charged over UK train stabbings

A man has been charged with 10 counts of attempted murder following a mass stabbing on a London-bound train, as a critically wounded train worker was hailed Monday as a hero for stepping in to protect passengers.

Spain regional leader resigns, a year after deadly floods

The heavily criticised leader of Spain's Valencia region said on Monday he was stepping down, a year after the area was hit by floods that were the country's deadliest natural disaster in a generation.

Video game creators fear AI could grab the controller

Generative artificial intelligence models capable of dreaming up ultra-realistic characters and virtual universes could make for cheaper, better video games in future, but the emerging technology has artists and developers on edge.

Afghan govt says quake kills 20, injures over 500

A strong earthquake killed at least 20 people in northern Afghanistan, authorities said Monday, just months after another deadly tremor that left the country reeling.

Afghanistan quake kills 20, injures over 300: health ministry